AL137-ABC / Alector - LARVOL DELTA

Alector Brain Carrier: Preclinical and Research Pipeline - AL137 (GlobeNewswire) - "Alector has selected lead candidate AL137 for its ABC-enabled anti-amyloid beta (Aβ) antibody in Alzheimer’s disease (AD) and is advancing it toward investigational new drug (IND)-enabling studies. The company is targeting an IND filing for AL137 in 2026."

IND • Alzheimer's Disease